ZIM3 activation of CCL25 expression in pulmonary metastatic nodules of osteosarcoma recruits M2 macrophages to promote metastatic growth-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

ZIM3 activation of CCL25 expression in pulmonary metastatic nodules of osteosarcoma recruits M2 macrophages to promote metastatic growth

Published:2022-09-26 Issue:4 Volume:72 Page:903-916
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Li Jing,Zhao Chenguang,Wang Dong,Wang Shuang,Dong Hui,Wang Difan,Yang Yubing,Li Jiaxi,Cui Feng,He Xijing,Qin Jie

Funder

National Key Research and Development Program of China

Shaanxi Province Innovation Talent Promotion Program -Youth Science and Technology Star Project

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

https://link.springer.com/content/pdf/10.1007/s00262-022-03300-7.pdf

Reference60 articles.

1. Casali PG, Bielack S, Abecassis N et al (2018) Bone sarcomas: ESMO-PaedCan-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 29:iv79–iv95. https://doi.org/10.1093/annonc/mdy310

2. Alexander JH, Binitie OT, Letson GD, Joyce DM (2021) Osteosarcoma: an evolving understanding of a complex disease. J Am Acad Orthop Surg 29:e993–e1004. https://doi.org/10.5435/jaaos-d-20-00838

3. Harrison DJ, Geller DS, Gill JD, Lewis VO, Gorlick R (2018) Current and future therapeutic approaches for osteosarcoma. Expert Rev Anticancer Ther 18:39–50. https://doi.org/10.1080/14737140.2018.1413939

4. Meazza C, Scanagatta P (2016) Metastatic osteosarcoma: a challenging multidisciplinary treatment. Expert Rev Anticancer Ther 16:543–556. https://doi.org/10.1586/14737140.2016.1168697

5. Huang J, Li J, Zheng S et al (2020) Tumor microenvironment characterization identifies two lung adenocarcinoma subtypes with specific immune and metabolic state. Cancer Sci 111:1876–1886. https://doi.org/10.1111/cas.14390

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in osteosarcoma management: integrating immune microenvironment insights with immunotherapeutic strategies;Frontiers in Cell and Developmental Biology;2024-06-10

2. PCSK9 promotes tumor cell proliferation and migration by facilitating CCL25 secretion in esophageal squamous cell carcinoma;Oncology Letters;2023-10-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3